Home/Pipeline/ClearCell® FX1 System

ClearCell® FX1 System

Circulating Tumour Cell Enrichment for Oncology

CommercialActive

Key Facts

Indication
Circulating Tumour Cell Enrichment for Oncology
Phase
Commercial
Status
Active
Company

About Biolidics

Innovative Singapore diagnostics firm delivering label‑free CTC enrichment and rapid COVID‑19 test kits.

View full company profile